Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Cryotherapy is emerging as a promising, low-risk approach to combat chemotherapy-induced peripheral neuropathy, a common and potentially devastating toxicity of chemotherapy. A growing body of ...

In a recent study published in JAMA Internal Medicine, researchers examine the potential of neuromuscular training to prevent chemotherapy-induced peripheral neuropathy (CIPN). Study: Preventive ...

A French-American research team discovered that the investigational compound Carba1 may prevent chemotherapy-induced peripheral neuropathy (CIPN) in preclinical models. According to a study published ...

Patients treated with platinum-based agents and taxanes had the highest prevalence of chronic painful CIPN (40.44% and 38.35%, respectively). HealthDay News — The pooled prevalence of chronic painful ...

People who participated in an exercise program during chemo were significantly less likely to experience painful symptoms of nerve damage. Many chemotherapy drugs cause damage to the nerves, ...

“Neurotoxic chemotherapy can cause permanent nerve damage in the feet, leading to numbness, burning, a loss of feeling, and a ‘pins and needles’ sensation. Because it reduces balance and muscle ...

Chemotherapy-induced peripheral neuropathy (CIPN) affects cancer survivors, impacting quality of life. Podiatry care can help manage symptoms and complications.